Evidence map›Paper›PMID 24114261›Full record

ArticleJournal of the American Society for Mass Spectrometry2014

False-positive rate determination of protein target discovery using a covalent modification- and mass spectrometry-based proteomics platform.

Erin C Strickland, M Ariel Geer, Jiyong Hong, Michael C Fitzgerald

Abstract read
In one paragraph

Article in Journal of the American Society for Mass Spectrometry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.4field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 14 citations in OpenAlex.

  1. The Knowns and Unknowns in Protein-Metabolite Interactions.International journal of molecular sciences · 2023
    Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Erin C StricklandDepartment of Chemistry, Duke University, Durham, NC, 27708, USA.
M Ariel Geer
Jiyong Hong
Michael C Fitzgerald
Duke University · US

Funding

Analysis of Protein-Ligand Binding on the Proteomic ScaleR01GM084174 · NIGMS · DUKE UNIVERSITY · PI FITZGERALD, MICHAEL C · 2009 to 2017
$2.6M
Purchase of a Q-TOF LC/MS SystemS10RR027746 · NCRR · DUKE UNIVERSITY · PI FITZGERALD, MICHAEL C · 2010 to 2010
$369k
NCRR NIH HHS S10 RR027746NIGMS NIH HHS GM084174NIGMS NIH HHS R01 GM084174
6 · The paper itself

Abstract

Detection and quantitation of protein-ligand binding interactions is important in many areas of biological research. Stability of proteins from rates of oxidation (SPROX) is an energetics-based technique for identifying the proteins targets of ligands in complex biological mixtures. Knowing the false-positive rate of protein target discovery in proteome-wide SPROX experiments is important for the correct interpretation of results. Reported here are the results of a control SPROX experiment in which chemical denaturation data is obtained on the proteins in two samples that originated from the same yeast lysate, as would be done in a typical SPROX experiment except that one sample would be spiked with the test ligand. False-positive rates of 1.2-2.2% and <0.8% are calculated for SPROX experiments using Q-TOF and Orbitrap mass spectrometer systems, respectively. Our results indicate that the false-positive rate is largely determined by random errors associated with the mass spectral analysis of the isobaric mass tag (e.g., iTRAQ®) reporter ions used for peptide quantitation. Our results also suggest that technical replicates can be used to effectively eliminate such false positives that result from this random error, as is demonstrated in a SPROX experiment to identify yeast protein targets of the drug, manassantin A. The impact of ion purity in the tandem mass spectral analyses and of background oxidation on the false-positive rate of protein target discovery using SPROX is also discussed.

Indexed as

ProteomicsDrug DiscoveryLigandsLignansMass SpectrometryModels, ChemicalProtein BindingProteinsReproducibility of ResultsSaccharomyces cerevisiaeThermodynamicsLigandsLignansmanassantin AProteins

Identifiers

PMID24114261
PMCPMC3880622
OpenAlexW2059241730

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.